Blue Fin Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Blue Fin Capital's EW Position: Q3 2026 in Review
Blue Fin Capital reduced its Edwards Lifesciences (EW) stake by 1.8% in Q3 2026, selling an estimated $4.27K and leaving 2,575 shares worth $222K. The position accounts for 0.03% of the portfolio, ranked #159.
Blue Fin Capital first reported a position in EW in Q2 2024 and has held it in 7 quarters since. The position peaked at $238K in Q2 2024. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Blue Fin Capital held 2,575 shares of Edwards Lifesciences worth $222K as of Q3 2026.
- Blue Fin Capital sold 48 Edwards Lifesciences shares in Q3 2026, an estimated $4.27K.
- Edwards Lifesciences made up 0.03% of Blue Fin Capital's portfolio in Q3 2026, its #159 holding.
- Blue Fin Capital first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 7 quarters since.
- Blue Fin Capital's Edwards Lifesciences position peaked at $238K in Q2 2024.
- 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Blue Fin Capital's 13F filing for Q3 2026, filed 28 Oct 2026.